Episode
The Golden Triangle and the gaps: Rethinking UK biotech
- Podcast
- BioSpace
- Published
- Jun 25, 2026
- Duration seconds
- 1177
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/biospace-6696251/episodes/the-golden-triangle-and-the-gaps-rethinking-uk-biotech/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/biospace-6696251/the-golden-triangle-and-the-gaps-rethinking-uk-biotech.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
In this episode of Denatured, as part of our series on the European life sciences investment ecosystem, you’ll hear from Hakan Goker, managing director at M Ventures and Maina Bhaman, partner at Sofinnova Partners. We explore the UK biotech ecosystem : from the Golden Triangle’s evolving role to the challenges of scaling companies, unlocking pension capital and staying globally competitive. Host Jennifer C. Smith-Parker , Director of Insights, BioSpace Guests Hakan Goker , Managing Director, M Ventures Maina Bhaman , Partner, Sofinnova Partners Disclaimer: The views expressed in this discussion by guests are their own and do not represent those of their organizations.